Skip to main content

Select Drug Profiles

Practice Management
Inpatient Utilization and Costs for Medicare Fee-for-Service Beneficiaries with Heart Failure
Kathryn Fitch, RN, MEd, Pamela M. Pelizzari, MPH, Bruce S. Pyenson, FSA, MAAA
Stakeholder Perspective
Validating the Impact of Heart Failure Through the Law of Large Numbers
by Albert Tzeel, MD, MHSA, CPE, FAAPL
Read More
FDA Approvals, In the News
Venclexta FDA Approved for Patients with CLL
Read More
Letters to the Editor, In the News
Correspondence: Developing a Model Framework to Assess Cost of Therapy
Read More
FDA Approvals, In the News
FDA Approves Infliximab Biosimilar for Multiple Indications
Read More
FDA Approvals, In the News
FDA Expands Use of Xalkori to Treat Rare Form of Advanced Non-Small Cell Lung Cancer
Read More
FDA Approvals, In the News
FDA Approves First Treatment for Rare Disease in Patients Who Receive Stem Cell Transplant from Blood or Bone Marrow
Read More
FDA Approvals, In the News
FDA Approves First Coagulation Factor-Albumin Fusion Protein to Treat Patients with Hemophilia B
Read More
Conquering COPD: Value-Based Perspectives for Providers and Payers
Jill Ohar, MD, Kenneth L. Schaecher, MD, FACP, CPC, John A. Welz, MPH
Read More
FDA Approvals, Payers' Guide
The Year 2015 Had Highest Number of Drug Approvals in the New Millennium, but with Controversy
Gary M. Owens, MD
Read More
FDA Approvals, Payers' Guide
FDA Approvals of Brand-Name Prescription Drugs in 2015
Read More
Page 114 of 244
Results 1131 - 1140 of 2438